Inventor · disambiguated record
Peter Richardson
Also filed as: RICHARDSON PETER · RICHARDSON PETER J
33 granted patents·25 pending applications·360 citations·filing 1984–2024
97Inventor score
Top patents by PatentIndex Score
58 records- 0197US8372804B2Delivery of active agentsMANNKIND CORP·Filed 2008·Granted Feb 12, 2013·60 cites·21 claims
- 0296US8377869B2Method of preventing adverse effects by GLP-1MANNKIND CORP·Filed 2008·Granted Feb 19, 2013·57 cites·20 claims
- 0396US8119593B2Method of treating diabetes type 2 by metformin and an ultrarapid acting insulinRICHARDSON PETER·Filed 2009·Granted Feb 21, 2012·110 cites·33 claims
- 0492US8911496B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2012·Granted Dec 16, 2014·27 cites·20 claims
- 0589US2024197836A1Method of treating diabetes type 2 by administering ultrarapid acting insulinMANNKIND CORP·Filed 2024·Application pending·0 cites
- 0687US9504559B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2015·Granted Nov 29, 2016·4 cites·20 claims
- 0786US9717588B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2016·Granted Aug 1, 2017·4 cites·20 claims
- 0886US2024197627A1Delivery of active agentsMANNKIND CORP·Filed 2024·Application pending·0 cites
- 0985US10285804B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2017·Granted May 14, 2019·3 cites·20 claims
- 1081US11304992B2Inhalable dry powder pharmaceutical compositionMANNKIND CORP·Filed 2019·Granted Apr 19, 2022·1 cites·6 claims
- 1181US9730785B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2016·Granted Aug 15, 2017·2 cites·20 claims
- 1281US9700406B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2016·Granted Jul 11, 2017·2 cites·20 claims
- 1381US9687339B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2016·Granted Jun 27, 2017·2 cites·20 claims
- 1481US9498324B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2015·Granted Nov 22, 2016·2 cites·21 claims
- 1581US9452044B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2015·Granted Sep 27, 2016·2 cites·20 claims
- 1681US2022362147A1Delivery of Active AgentsMANNKIND CORP·Filed 2022·Application pending·0 cites
- 1778US8409277B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsGRIFFIS III JACK C·Filed 2007·Granted Apr 2, 2013·15 cites·37 claims
- 1877US9486310B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2014·Granted Nov 8, 2016·4 cites·21 claims
- 1977US2022387593A1Method of preventing adverse effects by glp-1MANNKIND CORP·Filed 2022·Application pending·0 cites
- 2076US11998591B2Method of treating diabetes type 2 by administering ultrarapid acting insulinMANNKIND CORP·Filed 2020·Granted Jun 4, 2024·0 cites·11 claims
- 2175US11273028B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2020·Granted Mar 15, 2022·0 cites·23 claims
- 2275US8623817B2Method of treating diabetes type 2 by administering ultrarapid acting insulinRICHARDSON PETER·Filed 2012·Granted Jan 7, 2014·1 cites·20 claims
- 2373US8921311B2Method for treating hyperglycemiaCOSTELLO DONALD·Filed 2011·Granted Dec 30, 2014·1 cites·28 claims
- 2473US8709029B2Apparatus and method for securing ocular tissueGRIFFIS III JACK C·Filed 2007·Granted Apr 29, 2014·8 cites·26 claims
- 2572US7790698B2Use of adenosine receptor agonists in therapyCAMBRIDGE BIOTECHNOLOGY LTD·Filed 2004·Granted Sep 7, 2010·6 cites·14 claims
- 2670US10857207B2Method of treating diabetes type 2 by administering ultrarapid acting insulinMANNKIND CORP·Filed 2018·Granted Dec 8, 2020·0 cites·5 claims
- 2770US7927372B2Scleral prosthesis having crossbars for treating presbyopia and other eye disordersREFOCUS GROUP INC·Filed 2008·Granted Apr 19, 2011·6 cites·21 claims
- 2868US10485653B2Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methodsREFOCUS GROUP INC·Filed 2019·Granted Nov 26, 2019·0 cites·20 claims
- 2968US2020146981A1Delivery of active agentsMANNKIND CORP·Filed 2020·Application pending·0 cites
- 3067US9943571B2Use of ultrarapid acting insulinMANNKIND CORP·Filed 2013·Granted Apr 17, 2018·0 cites·23 claims
- 3167US9078866B2Method for treating hyperglycemia with GLP-1COSTELLO DONALD·Filed 2010·Granted Jul 14, 2015·2 cites·12 claims
- 3266US7759321B2Compounds for the treatment of painCAMBRIDGE BIOTECHNOLOGY LTD·Filed 2004·Granted Jul 20, 2010·6 cites·16 claims
- 3366US2019167580A1Delivery of Active AgentsMANNKIND CORP·Filed 2019·Application pending·0 cites
- 3464US2020147219A1Method of preventing adverse effects by glp-1MANNKIND CORP·Filed 2020·Application pending·0 cites
- 3563US8252766B2Use of spongosine for the treatment of painRICHARDSON PETER·Filed 2003·Granted Aug 28, 2012·1 cites·40 claims
- 3663US2015080298A1Method for treating hyperglycemiaMANNKIND CORP·Filed 2014·Application pending·0 cites
- 3762US11369616B2Drug combination and its use in therapyPROXIMAGEN LLC·Filed 2018·Granted Jun 28, 2022·0 cites·10 claims
- 3861US2013118491A1Delivery of Active AgentsMANNKIND CORP·Filed 2013·Application pending·0 cites
- 3960US6331520B1Pharmaceutical compositions of peptides having low solubility in physiological mediumAPPLIED RESEARCH SYSTEMS·Filed 1999·Granted Dec 18, 2001·15 cites·6 claims
- 4060US2020397764A1Vap-1 inhibitors for treating painBENEVOLENTAI CAMBRIDGE LTD·Filed 2020·Application pending·0 cites
- 4159US4999250AComposition and useICI PLC·Filed 1988·Granted Mar 12, 1991·16 cites·19 claims
- 4259US2023293436A1Inhalable dry powder pharmaceutical compositionMANNKIND CORP·Filed 2022·Application pending·0 cites
- 4356US2013125886A1Method of preventing adverse effects by glp-1RICHARDSON PETER·Filed 2013·Application pending·0 cites
- 4455US2017304404A1Method for treating hyperglycemia with glp-1MANNKIND CORP·Filed 2017·Application pending·0 cites
- 4553US2022347189A1Methods of treating eosinophilic esophagitis and reducing candidiasisELLODI PHARMACEUTICALS L P·Filed 2020·Application pending·0 cites
- 4650US4550206AMethod of preparing tetrahalobenzene compounds, chemical intermediates used therein and certain of the compounds themselvesICI LTD·Filed 1984·Granted Oct 29, 1985·3 cites·7 claims
- 4750US2015283213A1Method for treating hyperglycemia with glp-1MANNKIND CORP·Filed 2015·Application pending·0 cites
- 4845US2007059773A1Identification of therapeutic compoundsRICHARDSON PETER·Filed 2004·Application pending·0 cites
- 4945US2018360808A1Vap-1 inhibitors for treating painBENEVOLENTAI CAMBRIDGE LTD·Filed 2016·Application pending·0 cites
- 5045US2021069189A1Treatment of neurodegenerative diseasesBENEVOLENTAI BIO LTD·Filed 2018·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →